Navigation Links
Cymbet EnerChip Solid State Batteries Verified 100% Biocompatible
Date:5/13/2013

Nuremberg, Germany (PRWEB) May 14, 2013

Cymbet Corporation announced today at the PCIM Europe show the successful results of in vivo biocompatibility feasibility studies that were conducted to evaluate the biological safety of the EnerChip™ Rechargeable Solid State Battery. EnerChip bare die batteries were crushed and combined into a saline solution which was introduced into an in vivo test setting. No ill effects were recorded nor were any test article related lesions observed in this study.

These excellent in vivo test results reinforce similar findings from Cymbet’s July 2012 in vitro studies in which EnerChip bare die battery samples were gamma sterilized and evaluated using two in vitro test methods for cytotoxicity and the EnerChips demonstrated 100% non-cytotoxicity.

Cymbet EnerChip solid state batteries are uniquely fabricated using standard semiconductor manufacturing processes using patented construction techniques. One of the most rigorous ways to test the intrinsic biological safety of the EnerChip battery is to introduce crushed EnerChip bare die into in vivo test settings. Crushing the battery replicates the case of an EnerChip-powered implanted medical device that is catastrophically destroyed. In this trauma situation, the EnerChip battery components would be exposed directly to the in vivo setting. The results of this in vivo testing showed no harmful effects from having the crushed EnerChips in the body.

EnerChip Solid State Batteries are uniquely safe for use in new product designs. EnerChip batteries have the same handling and die attach mechanisms as the other Integrated Circuits found in electronic devices. This makes EnerChips ideal for co-packaging with other ICs to create advanced Systems-in-Package (SIP) devices. EnerChips are also packaged in standard plastic DFN semiconductor packages that ship on tape and reel. There are many global environmental and safety standards and di
'/>"/>

Source: PRWeb
Copyright©2012 Vocus, Inc.
All rights reserved

Page: 1 2

Related medicine news :

1. Cymbet Secures $20 Million Investment
2. Smith & Nephew Hip Recall News: Bernstein Liebhard LLP Notes Motion to Consolidate Smith & Nephew Lawsuits Filed in Tennessee State Courts
3. Solid-state controllable light filter may protect preterm infants from disturbing light
4. Transvaginal Mesh Complications Lawsuits Update: Resource4thePeople Reports Some CasesDismissed from Consolidated Litigation
5. New Instrument for High-Precision Measurements of Soy Milk Solids and Protein Concentration
6. Consolidated Facility Advises Spring Cleaning Done Now in Davis Businesses
7. AACR: Positive data supports advancing BIND-014 to phase 2 clinical trials for solid tumors
8. Researchers to develop next generation immunotherapy for children with deadly solid tumors
9. Four in 10 Babies Given Solid Foods Too Early, Study Finds
10. Sleep consolidates memories for competing tasks
11. Accelerated Debt Consolidation, Inc. Offers Tips to Help Determine if Consumers are Heading Toward Financial Problems; New Statistical Data Shows Increased Delinquencies
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/30/2014)... 2014 Everyone knows that the internet is ... Whether people are looking for something to buy, trying to ... the internet is pretty much always going to be the ... Lauderdale Florida is so happy to announce the launch of ... into the modern age. Whether a person wants to know ...
(Date:7/30/2014)... 2014 “North America Contrast Media Injectors ... the North America Contrast Media Injectors market. The report ... (in units) and average price data (in US dollars), ...     Interventional Cardiology/Angio Injectors and MRI Injectors ... a substance used to enhance the contrast of structures ...
(Date:7/30/2014)... Association for Vedic Studies (WAVES) conference is coming to ... July 31 through Sunday, August 3. To watch the ... is the first time such a large and diverse ... campus to explore the relevance of ancient Vedic knowledge ... higher states of consciousness, and reflections on the various ...
(Date:7/30/2014)... Washington, DC (PRWEB) July 30, 2014 ... have recently joined the Board of Directors of ... provides guidance for the Association, which has a ... in healthcare delivery through telecommunications and information technology. ... members of the Association, possess extraordinary expertise and ...
(Date:7/30/2014)... global digital pathology market was valued at an estimated $250.2 ... CAGR of 11.8%, to reach an estimated $437 million by ... is expected to continue to rise in the coming years ... enable pathologists to be efficient and this leads to improved ... market was valued at $128.9 million and accounted for the ...
Breaking Medicine News(10 mins):Health News:Sierra Dental Releases New Website For Fort Lauderdale Residents 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 2Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 3Health News:Contrast Media Injectors Market in North America (US, Canada, Mexico) to 2020 Report Available at MarketOptimizer.org 4Health News:Vedic living in a modern world: International conference at Maharishi University 2Health News:Vedic living in a modern world: International conference at Maharishi University 3Health News:American Telemedicine Association Welcomes Two New Members to the Board of Directors 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 2Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 3Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 4Health News:Global Digital Pathology Market To See 11.8% CAGR to 2018 Says a New Research Report Available at ReportsnReports.com 5
... decided to launch a ban on sale of Colas and junk ... and junk food may be out of school canteens across the ... are bad for children’s health. Hence, we want to ban the ... with Union Human Resource Development Ministry on the legal aspects of ...
... cancer is available in Singapore for those between the ... ,The Health Sciences Authority (HSA) gave its approval ... similar vaccine, Cervarix, from competitor GlaxoSmithKline, is awaiting approval ... health breakthrough, said Tay Eng Hseon, a doctor at ...
... gas tragedy survivors' organisations claimed //to have seized a ... medical stores of the Bhopal Gas Tragedy Relief and ... organisations, working for the victims of the world's worst ... their expiry date," Rachna Dhingra of Bhopal Group of ...
... donated $30 million to University Hospitals (UH), a major ... turned his graduate thesis into a global automotive business ... himself, his wife Usha and their family, in support ... 2010. ,In recognition of the Ahuja family's ...
... treatment to remove lead from the body -- can significantly ... a// Cornell study of young rats finds. ,However, ... of autistic children, the researchers say that when rats with ... chemical, they showed declines in their learning and behavior that ...
... on women in their 70's to observe the relationship between ... followed nearly 12,000 women in// their 70’s over a 6 ... for 3-6 days/week, depending on alcoholic content) may lead to ... ,This study was published in Journal of the American ...
Cached Medicine News:Health News:Indian American Donates $30 Mn to Healthcare System 2Health News:Pros and Cons of Therapy for Lead Exposure 2
(Date:7/30/2014)... DIEGO , July 30, 2014   ... biotech company that designs and develops novel diagnostics ... of cancer, announced today the completion of a ... financing included new investors RusnanoMedInvest (RMI) and Arcus ... and Pfizer Venture Investments, as well as undisclosed ...
(Date:7/30/2014)... , 30. Juli 2014 ... ein führender Anbieter im Bereich Atemtherapie- und ... des Landgerichts München in Deutschland anfechten werden. ... bestimmten Masken ein Patent von ResMed verletze. ... in wichtigen Ländern gegen verschiedene Patente von ...
(Date:7/29/2014)... Amgen (NASDAQ: AMGN ) today ... Key results include: , Total revenues increased 11 ... growth driven by strong performance across the portfolio, particularly ... ® (denosumab) and XGEVA ® (denosumab). ... by higher revenues and a significant increase in the ...
Breaking Medicine Technology:Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 2Epic Sciences Announces Series C Financing to Advance Essential Cancer Diagnostics for Personalized Medicine 3Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 2Apex setzt seinen Kampf gegen Patente für einen freien Wettbewerb fort 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 2Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 3Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 4Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 5Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 6Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 7Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 8Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 9Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 10Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 11Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 12Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 13Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 14Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 15Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 16Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 17Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 18Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 19Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 20Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 21Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 22Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 23Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 24Amgen's Second Quarter 2014 Revenues Increased 11 Percent To $5.2 Billion And Adjusted Earnings Per Share (EPS) Increased 25 Percent To $2.37 25
... SUNNYVALE, Calif., Dec. 28, 2010 Accuray Incorporated (Nasdaq: ... radiosurgery, announced today that its president and chief executive officer, ... 29th Annual J.P. Morgan Healthcare Conference in San Francisco on ... A live webcast of the presentation will be ...
... Medical Group Inc. (Nasdaq: WWIN ), ("Winner ... and non-woven fabric made from 100% natural PurCotton® products ... was recently held by Winner Medical and Cotton Incorporated ... in a high footprint shopping mall in Shanghai. ...
Cached Medicine Technology:Accuray Incorporated's CEO to Speak at 29th Annual J.P. Morgan Healthcare Conference 2Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai 2Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai 3Winner Medical and Cotton Inc. Promote PurCotton(R) Brand and Natural(TM) Trademark in Shanghai 4
... The UST-9121 is an ... sector transducer with a wide ... frequencies, this transducer is designed ... an intercostal window. The versatility ...
... transducer is a curved ... the higher frequencies. Featuring ... this transducer provides exceptional ... frequency abdominal kidney bladder ...
... to Enzo Clinical Labs, a full service ... the leading regional labs in the country, ... of a large laboratory with the convenience ... Enzo was one of the area's first ...
... Test System* is a multiplexed, fluorescent, ... multiple assays from a single sample ... a simple and streamlined alternative to ... clinical sensitivity and comparable clinical specificity ...
Medicine Products: